WHO Backs Pfizer’s Paxlovid For High-Risk COVID-19 Patients
But Access Obstacles Remain In Lower-Income Countries
An international group of experts has issued new guidance on the use of therapeutics in patients with non-severe COVID-19.
An international group of experts has issued new guidance on the use of therapeutics in patients with non-severe COVID-19.